Researchers warn that men who regularly avoid prostate cancer selection promises are 45% more likely to die from disease.
According to UC SAN Francisco (UCSF), prostate cancer is the most common cancer among men and the second main cause of cancer death.
However, if the selection program is introduced to the state, especially in the blood, experts say that the level of prostate-specific antigens (PSA) can be approached earlier.
As the doctor shares the reason, the prostate cancer cases are soaring in the United States.
According to the news agency SWNS and other people’s reports, they will be more likely to be treated.
The screening test can also prevent the cost -related treatment related to the progressive prostate cancer.
The new study examines the connection between the consistent reduction of male tests and the risk of dying of prostate cancer. It shows a “clear contrast” that emphasizes the potential results of the examination. (Istock)
This is based on the European randomly research data of the prostate cancer screening test (ERSPC).
This study collects information from seven European countries, including Finland, the Netherlands, Italy, Sweden, Switzerland, Belgium and Spain. SWNS is called the world’s largest prostate cancer selection study.
Typical cancer types can be detected by new blood tests.
Long -term data in this reality continues to show that PSA selection programs can reduce the risk of death by 20% due to prostate cancer.
‘Stark preparation’
Now, as a result of analyzing the 20 -year subsequent data of ERSPC, we will first look at the connection between the consistent reduction of the selection invitation and the danger of death with this type of cancer.
It shows a “clear contrast” that emphasizes the potential results of the examination.
One out of six of the 72,460 men invited to participate in the 72,460 selections was a non -subspecies and skipped all promises.
Researchers at the Erasmus MC Cancer Institute at the University of Medical Center, SWNS said, SWNS said.
Of the 72,460 men, one out of six men invited to participate in the screening was a non -species and skipped all promises.
The group had a 45% higher risk of dying as a prostate cancer than those who attended the promise.
One expert said that choosing not to participate in the screening is a choice that can be led by a complex element collection. (Istock)
According to SWNS, SWNS, those who participated in the screening test compared the results with those who did not receive the screening test, and those who attended the promise to select inspection were 23% lower in prostate cancer, and non-participants faced a 39% higher risk, SWNS reported.
The chief research author Renée Leenen, MD, and Ph.D. said that choosing not to participate in the selection can be led by complex factors.
Click here to join the Health Newsletter.
LEENEN, with the Erasmus CM Cancer Institute in the Netherlands, said, “A man who is chosen not to attend a sorting promise may be a person who avoids treatment.
Experts say, “You should better understand who these men are, why you chose not to attend the promise, and how to motivate them.”
She added: “This is probably the opposite of those who are more likely to rely on health and attend a sorting promise. Our research is invited for a screening test, but a man who has not attended a screening promise is quite risk of death as a prostate cancer compared to a man who is not invited to scraming.”
Long -term data in this reality continues to show that PSA selection programs can reduce the risk of death by 20% due to prostate cancer. (Istock)
Dr. Leenen said, “You have to better understand how these people are, why you choose not to attend the promise, and how to motivate them.
SWNS added: “We will help to design a population -based prostate cancer selection program that increases the participation rate based on information.
Visit to see more healthy articles www.foxnews.com/health
Dr. Tobias Nordström in Karolinska Institute in Sweden said, “Even though we were invited to attend these people, we need to better understand why this behavior is related to the worse consequences when it is diagnosed,” he said.
The findings will be published this weekend at the European Urology Association (EAU) parliamentary parliament, SWNS said.
Click here to get the Fox News app
Dr. Marc Siegel, a senior medical analyst at FOX News, who is not involved in new studies on prostate cancer risks, previously demanded the need for regular medical examination.
Siegel emphasized “the need to diagnose early for better results.”
Fox News Digital’s Angelica Stabile contributed to the report.
